Testosterone Treatment and Fractures in Men with Hypogonadism
A randomized controlled trial published in the New England Journal of Medicine examined the effects of testosterone therapy on fracture risk in men with hypogonadism. The study included 5,204 men aged 45 to 80 with hypogonadism and cardiovascular risk factors, who were randomized to receive either testosterone gel or placebo